University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging ...(update or revise them to reflect new eve...),Health
Navigation Links
University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
Date:5/14/2008
update or revise them to reflect new events or circumstances.
'/>"/>
| SOURCE IMRIS Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
2. Depression and anger can plague recent university graduates: Study
3. American Sentinel University Accepting Enrollment in Online RN to BS in Nursing
4. Think before you drink, says university research
5. University of Leicester to lead audit of adults with autism
6. San Diego State University Controlled Substance Investigation
7. Tel Aviv University finds connection between mental fitness and multi-lingualism
8. Health Care Corporate Compliance Certificate Program to Be Offered at Hamline University School of Laws Health Law Institute
9. Boston Medical Center/Boston University School of Medicine researcher receives award
10. University Hospitals Physician Authors Working Womans Pregnancy Book
11. Amscot Financial Contributes to Bethune-Cookman University School of Nursing, Supporting Healthcare Education
Post Your Comments:
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)..., Va., Nov. 21 The Gene...e following statement today from,GPhA President a... Commission,(FTC) roundtable on "Emerging Health ...he mere fact that the FTC is conducting this round...suring that consumers have access to safe and,aff...
(Date:11/21/2008)...N, W.Va., Nov. 21 New r... whether a smokeless, spitless tobacco product aim...hers have found that RJ Reynolds, Camel Snus - tou...ion - contains surprisingly high levels of nicotin...han most other snuff products," said Bruce Adkins ...
(Date:11/21/2008)...LAKES, N.J., Nov. 21 Tod...dical intervention in treating 88 percent of patie...of Americans treated for a chronic condition accou...g and 75 percent of all medical costs. A propriet...by Medco Health Solutions, Inc. (NYSE: MHS ) sig...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6[0] Med school discovery could lead to better cancer diagnosis, drugs[0] GPhA Statement on FTC Roundtable on Biogenerics[0] Experts Say New Tobacco Product Targets Young Adults[0] New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
...isk increase by gene variant A group of research ...omanian colleagues has discovered a gene variant w...one considerably (Hepatology No. 46, 11 July 2007,...e on ten Europeans has this variant in their genet...
...ty prevalence increased from 13 percent to 32 perc...rchers at the Johns Hopkins Bloomberg School of Pu...lence of obesity and overweight has increased at a...nts across different sociodemographic groups over ...
...selective of its reaction to a particular variety ...i . According to Biology textbooks neutrophils are...WBC) form an integral part of blood. They are the ...y. They protect our body from various kinds of inf...
... Dana-Farber Cancer Institute have identified a lo...on of brown fat , a type of adipose tissue that ge...ting. A team headed by Bruce Spiegelman, PhD, sug...ism that turning up the equivalent switch in peopl...
Other Medicine News:Health News:Gallstone Gene Discovered by Research Team 2Health News:U.S Shows Increased Obesity Rate 2Health News:WBC Selective About Sugar 2Health News:Scientists Identified Obesity Control Switch 2(Date:11/20/2008)..., Nov. 20 PAREXEL Intern...lobal biopharmaceutical services provider, today a...u to provide regulatory consulting and clinical re... office, PAREXEL now has locations throughout five...ica, which also include Argentina, Brazil, Chile, ...
(Date:11/19/2008)...ND OAKS, Calif., Nov. 19 ...da Oncology Company, a subsidiary of,Takeda Pharm...nced that,enrollment in the Phase 3 MONET1 trial ...h paclitaxel and carboplatin for the first-line tr...SCLC) has been temporarily suspended,following a ...
(Date:11/19/2008)...CHELLE, N.Y., Nov. 19 Biotech scie...gies to toxicology research to better understand t...f organ systems, reports Genetic Engineering &... interested in figuring out a new compound,s mecha...ive toxicology technique, according to the Novembe...
(Date:11/18/2008)..., November 19 NeuroDisco...vice provider and drug development Company,and S...: 4565), a leading,international biopharmaceutica...presenting further pivotal pre-clinical efficacy d...is a potential therapy for neuropathic pain and ha...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Saving the wild orchids of Borneo 4093 1Saving the wild orchids of Borneo 4093 2Genetic variant increases triglyceride levels in Asian Americans 4091 1Genetic variant increases triglyceride levels in Asian Americans 4091 2Researchers discover a gene that regulates and blocks ovulation 4089 1gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 1gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 2gloEMR Version 4 0 gloStream 26apos 3Bs Flagship Electronic Medical Record Solution Receives 2007 CCHIT Certification 24163 3[0] PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru[0] Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer[0] GEN Reports on the Trend Toward Predictive Toxicogenomics[4] Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
...swire-FirstCall/ -- Advanced Life,Sciences Holding...ial CL-06, the first of two pivotal Phase 3 clinic...iveness of cethromycin, a,novel once-a-day antibio...onia (CAP). In the study, cethromycin achieved,non...ol clinical,cure rate compared to Biaxin(R) (clari...
...o Nordisk today announced clinical,results from th...,the once-daily human GLP-1 analogue. The 26-week ...and Action in Diabetes) programme,and included 581...lled by two of the most widely used oral antidiabe...de). All patients in the,study continued the two o...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 2Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 3Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 4...dia 4000 is a hospital-grade Holter Monitoring Sys...Diogenes Arrhythmia and ST analysis algorithm, Hea...rdware and software. Facilities with an Epicardia ... reports, customizing them to suit their needs, an...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket.
...at™ System is the first thrombectomy catheter...licity for the full range of thrombus removal proc... the new ThromCat™ System flushes, macerates,...nd incorporates advanced vessel-wall safety featur...
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |